BioSpace News Archive

Pharm Country

Tevogen Bio Announces U.S. Patent and Trademark Office Has Granted Patent for Preparation of Tevogen’s SARS-CoV-2 Specific Allogeneic Cytotoxic T Lymphocytes (CTL)

Tevogen Bio today announced that the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent 11,191,827 which significantly reinforces Tevogen’s intellectual property position in use of SARS-CoV-2 specific Cytotoxic CD8+ T Lymphocytes (CTL).

December 8, 2021
·
4 min read
Business

Positive EMERALD Trial Results for Elacestrant Presented at San Antonio Breast Cancer Symposium 2021

The Menarini Group and Radius Health presented today at the San Antonio Breast Cancer Symposium (SABCS). The data was presented as a “Late Breaker” and shared in an oral presentation by Dr. Aditya Bardia, MD.

December 8, 2021
·
10 min read
Essence Group to Showcase Umbrella™, World’s First 5G-Enabled mPERS Solution, at CES 2022

Essence Group today announced it will showcase the world’s first 5G-enabled mobile personal emergency response system (mPERS) at CES 2022 in January.

December 8, 2021
·
3 min read
Biotech Beach

PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay

PharmaCyte Biotech, Inc. announced today the results of an additional, more detailed, analysis of the integration site of the cytochrome P450 2B1 gene from the augmented HEK293 cell clone that PharmaCyte uses in its CypCap™ product.

December 8, 2021
·
5 min read
Drug Development

PARI Nebulizer Successfully Delivers Pulmotect’s PUL-042 against COVID-19 in Two Phase 2 Studies

Pulmotect reported positive results from their second randomized, placebo-controlled Phase-2 trial of PUL-042 against COVID-19.

December 8, 2021
·
2 min read
Nordic Nanovector to Present at DNB’s 12th Nordic Healthcare Conference

Nordic Nanovector announces that its CEO, Erik Skullerud will present a corporate overview via live webcast at DNB’s 12th Nordic Healthcare Conference on 16 December 2021.

December 8, 2021
·
3 min read
GT Molecular Announces a Highly Sensitive Wastewater Testing Service for the Omicron Coronavirus Variant

GT Molecular, a company providing multiplexed, ultrasensitive PCR assays for wastewater-based epidemiology, cancer and pathogen panels, has announced the upcoming release of its sensitive PCR tests to monitor the coronavirus Omicron variant, B.1.1.529.

December 8, 2021
·
1 min read
Biotech Beach

EPIC sciences platform Demonstrates compelling Value of Cell Analysis in data Presented AT San Antonio Breast Cancer Symposium 2021

Epic Sciences, Inc. (Epic)'s comprehensive liquid-biopsy platform continues to deliver compelling cancer profiling information as data presented during the San Antonio Breast Cancer Symposium 2021 demonstrate.

December 8, 2021
·
2 min read
Pharm Country

Emendo Biotherapeutics to Present New Data at 63rd ASH Annual Meeting & Exhibition

Emendo Biotherapeutics, a next-generation CRISPR company expanding the reach of gene editing therapeutics, will be presenting a poster at the annual American Society of Hematology conference in Atlanta, taking place December 11-14, 2021.

December 8, 2021
·
1 min read
Glucose Meter Market Revenue Driven by Growing Awareness Regarding Self-Management of Diabetes: Reports and Data

Increasing incidence of diabetic population, launch of advanced wearable blood glucose meters, and rising government initiatives for availability of advanced healthcare facilities are some key factors expected to drive market growth.

December 8, 2021
·
8 min read